Shree Ganesh Biotech India News

Shree Ganesh Bio-Tech Reports FY26 Audited Results

Shree Ganesh Bio-Tech posts net profit of Rs. 37.76 lacs for FY26, up from Rs. 27.84 lacs in FY25, as revenue from operations declined to Rs. 497.05 lacs from Rs. 2,295.76 lacs.

Shree Ganesh Bio-Tech Board Meet Set for May 14, 2026

Shree Ganesh Bio-Tech schedules board meeting on May 14, 2026, to approve audited standalone financial results for the quarter and year ended March 31, 2026.

Shree Ganesh Bio-Tech Files Q4FY26 Demat Certificate

Shree Ganesh Bio-Tech (India) Limited submitted its quarterly certificate under SEBI regulations for Q4FY26, confirming no physical shares were received for dematerialization during the quarter.

Shree Ganesh Bio-Tech Reports Quarterly Financial Results for September 2025

Shree Ganesh Bio-Tech (India) Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The company reported revenue from operations of Rs 231.38 lakhs for the quarter compared to Rs 198.40 lakhs in the previous quarter. For the half year, revenue reached Rs 551.01 lakhs versus Rs 229.76 lakhs in the prior period. The company recorded a profit before tax of Rs 34.11 lakhs for the half year compared to Rs 56.12 lakhs in the previous year. The board meeting was held on November 8, 2025, where directors approved the financial results. The company operates in a single business segment and has undergone a limited review by statutory auditors.